| Neurodegenerative Press Releases + Feed Topics Locations Industries Dates
By Quintile Reports Neurodegenerative Disease Market was estimated at $55.21 billion in 2024 and is projected to reach $99.21 billion by 2034 reflecting a robust CAGR of 7.88% over the forecast period from 2024 to 2034: Quintile Reports
| By IGC PHARMA IGC Pharma, Inc. (NYSE American: IGC) proudly announces that it won 2 awards in the PREPARE Challenge (Pioneering Research for Early Prediction of Alzheimer's and Related Dementias EUREKA Challenge), with its entry of the Mexican Health and Aging Study...
| By NeuraWorx Medical Technologies, Inc. NeuraWorx Medical Technologies, Inc., a neurotechnology therapeutics company, announced today a partnership with prominent neuroscience venture builder and fund, Corundum Neuroscience.
|
Page updated every 10 minutes
| |